Vγ9Vδ2T Cell Culture Medium for Purity and Survival Balance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for human Vγ9Vδ2T cell proliferation suffer from low efficiency, low purity, short survival time, and weak anti-tumor killing ability, with conventional methods taking 14 days and resulting in cells surviving only about 7 days.
Innovation Solution
A method involving a two-step culture process using a first medium with interleukin-2, interleukin-15, and vitamin C or derivatives, followed by a second medium with interleukin-2, interleukin-15, and vitamin C, to stimulate and selectively proliferate Vγ9Vδ2T cells, achieving high purity and extended survival.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional culture medium with IL-2 and phosphate small molecule compound is used, then Vδ2T cell purity is improved, but cell survival time is shortened
Solution Approach 1:
The patent changes the chemical parameters of the culture medium by replacing phosphate small molecule compounds with vitamin C (ascorbic acid) and its derivatives. This parameter change maintains the selective proliferation capability for Vδ2T cells while simultaneously enhancing their anti-apoptotic ability and extending survival time from 7 days to over 14 days.
Solution Approach 2:
The patent creates a composite culture medium system by combining vitamin C (or derivatives) with interleukin-2 and other essential culture components. This composite approach synergistically improves both cell purity and survival time, resolving the contradiction between these two parameters.
2Productivity
If conventional culture method with 14 days proliferation period is used, then cell quantity is increased, but cell anti-apoptosis ability is weakened
Solution Approach 1:
By changing the culture medium composition to include vitamin C and its derivatives, the patent enhances the anti-apoptotic ability of proliferated cells while maintaining efficient cell expansion. This parameter change allows cells to acquire stronger survival capabilities during the proliferation process rather than weakening them.
Solution Approach 2:
Vitamin C acts as an intermediary substance in the culture medium that mediates between the proliferation signal and cell survival. It protects cells from apoptosis during the expansion process, enabling both high productivity and strong anti-apoptosis ability.
3Productivity
If monoclonal antibodies of IL-2 and TCR are added to culture medium, then T cell proliferation is stimulated, but Vδ1 cell subset is also proliferated causing immunosuppression
Solution Approach 1:
The patent changes the chemical parameters of the culture medium by using vitamin C and its derivatives instead of phosphate small molecule compounds in combination with IL-2. This parameter change maintains selective stimulation of Vδ2T cells while avoiding the proliferation of Vδ1 cells, thus preventing immunosuppression.
Solution Approach 2:
The patent converts the potential harm of non-specific T cell proliferation into a benefit by using vitamin C-enhanced culture conditions that selectively promote Vδ2T cell expansion. The vitamin C component helps differentiate and select the desired cell subset, turning a harmful side effect into a beneficial selective advantage.
Data Source
AI summary
A human Vγ9Vδ2T cell proliferation method and a culture medium. The method comprises: first stimulating a human Vγ9Vδ2T cell with a culture medium containing interleukin-2 and phosphonic acid compounds, and then culturing the human Vγ9Vδ2T cell with a culture medium added with interleukin-15 and vitamin C to achieve proliferation culture. The culture medium additionally comprises interleukin-15 and vitamin C. Compared with a conventional proliferation method and a conventional culture medium, the method and the culture medium can improve the proliferation efficiency and cell purity of the human Vγ9Vδ2T cell. The human Vγ9Vδ2T cell obtained by culture in the method has stronger anti-apoptotic ability and longer cell survival time, and moreover, the expression level of critical killer molecules NKG2D thereof is higher, thereby having stronger killing ability to tumor cells.